The Heart Transplant Program, part of the interdisciplinary Heart Institute, is the oldest pediatric heart transplant program in Ohio. We are part of the Heart Institute’s combined program linking cardiomyopathy/heart failure and mechanical circulatory support care.
Our team of cardiothoracic surgeons, cardiologists, nurse practitioners, and nurses are experts in the treatment of complex heart disease and heart transplantation. We care for infants, children, adolescents, and adults with uncorrectable congenital heart disease and cardiomyopathy, facilitating their candidacy for transplantation, and delivering their post-transplant care.
Our heart transplant program is approved by the United Network for Organ Sharing (UNOS) and a member of the Ohio Solid Organ Transplantation Consortium. In addition, our transplant team members are participants in the Pediatric Heart Transplant Study and the International Society for Heart and Lung Transplantation.
U.S. News & World Report ranks Cincinnati Children’s among the best in the nation in the 2019-20 guide to best children's hospitals.
Our Commitment to Quality Care
Our goal is to provide children facing untreatable heart disease the best chance to be active members of their families and communities, and the best chance to grow emotionally and physically with as little limitation as possible. Our areas of emphasis include:
- Care provided by a multidisciplinary team of cardiologists, surgeons, intensive care specialists, nurse practitioners, and nurses.
- Outcomes-focused clinical care and research to optimize survival and quality of life.
- Quality initiatives, such as prevention of rejection and use of cutting edge technologies to detect for harmful antibodies and detect for transplant coronary artery disease.
Our clinical team’s extensive experience and our commitment to long-term quality outcomes form the foundation of the Heart Transplant Program
Heart Transplantation Outcomes
We have performed more the 90 heart transplants in the program’s history, including patients one month old to 20 years old, and have a 95-100 percent one-year survival rate. (Survival rate 2009-2011 Scientific Registry of Transplant Recipients)